Return to Home

Xylem Inc.

XYL

Find Out if You Qualify for a Financial Reward by filling out the form below.

Xylem Inc. Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On August 9, 2023, Spruce Point Capital published a report raising “concerns about the accuracy of the Company’s cash liquidity.” Spruce Point Capital also alleged that it had “identif[ied] new evidence of accounting machinations ahead of Xylem’s acquisition” of Evoqua Water Technologies Corp.

On this news, Xylem’s stock price fell $2.82 to close at $102.00 per share on August 9, 2023, thereby injuring investors.

Find More Cases

Ticker Symbol Company Name Join Deadline
APLT Applied Therapeutics, Inc. February 18, 2025 Join
BIOA BioAge Labs, Inc. March 10, 2025 Join
PCRX Pacira BioSciences, Inc. March 14, 2025 Join
NVO Novo Nordisk A/S March 25, 2025 Join
GO Grocery Outlet Holding Corp. March 31, 2025 Join
NEM Newmont Corporation April 01, 2025 Join
GSK GSK plc April 07, 2025 Join
NTLA Intellia Therapeutics, Inc. April 14, 2025 Join